Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 541 to 544 of 544 results for iv

  1. NICE recommends elosulfase alfa for routine NHS use for patients with rare life-limiting metabolic disorder

    People with a rare condition that steadily worsens often leaving them dependent on a wheelchair and with shortened life expectancy, can now benefit from the first treatment to slow its progression.

    News
    Published
    21 March 2022

  2. NICE recommends first treatment in two decades for sickle cell disease

    Hundreds of people will be eligible for a new treatment for sickle cell disease following draft guidance published today (5 October).

    News
    Published
    5 October 2021

  3. NICE publishes new rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination

    NICE has today (29 July 2021) published a new rapid COVID-19 guideline to help healthcare staff identify and treat patients who develop the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving COVID-19 vaccinations.

    News
    Published
    29 July 2021

  4. Triple therapy recommended by NICE for patients with multiple myeloma

    The therapy has been recommended after a confidential discount was agreed between NHS England and the drug manufacturer Amgen.

    News
    Published
    22 March 2021